Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

CDC Notice of Intent to Sole Source for Inhalation Support / TSI MOUDI-II Instrument

Active
75D301-26-Q-98063Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Centers for Disease Control and Prevention (CDC) plans to award a sole-source contract for the purchase of a Micro Orifice Uniform-Deposit Impactor (MOUDI) from TSI Incorporated through simplified acquisition procedures. This procurement is justified because TSI is the only known supplier capable of providing a MOUDI instrument that meets the specific size classification requirements and the uniform sample deposition necessary for inhalation research. The contract will be a total small business set-aside under NAICS code 334516 and will support work to be performed in Morgantown, West Virginia. Interested parties are not being requested to submit competitive quotes, but those who believe they can fulfill the requirement may submit a capability statement by June 17, 2026, for consideration. The notice emphasizes that responding to this announcement does not guarantee the government will initiate a competitive procurement, and any costs incurred by responders will not be reimbursed. Questions and capability statements should be directed via email to the designated contract specialist, Aminah Gary, at the provided contact information. The decision to proceed with this sole-source acquisition rests solely with the government, which will use any received information to determine if competition is warranted. The solicitation number for this procurement is 75D301-26-Q-98063, and the official posting date is June 10, 2026.

General Info

CDC plans sole-source small business contract with TSI for MOUDI instrument, responses due June 17.

Agency

Department Of Health And Human Services → CDC Office Of Acquisition Services

NAICS

334516 - Analytical Laboratory Instrument Manufacturing View NAICS

Place of Performance

Morgantown, WV, USA

Set-Aside

SBA

Documents

(2)

TSI MOUDI-II Statement of Work

PDFsow

MOUDI II Impactors Model 120R and 125R Specification Sheet

PDFspecifications

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services
Contacts1 person available
OfficeATLANTA, GA, 30333, USA
Organization / Agency
Department Of Health And Human Services → CDC Office Of Acquisition Services
Office AddressATLANTA, GA, 30333, USA

Full Description

Show more

This is a notice of intent to award a sole-source contract using simplified acquisition procedures and is not a request for competitive quotes.


The Centers for Disease Control and Prevention (CDC) intends to award a sole-source purchase order using the procedures at RFO 12.102(a) as it has been deemed that only one source is available to meet this specific requirement due to the intended vendor, TSI Incorporated being the only company making a Micro Orifice Uniform-Deposit Impactors (MOUDI) that meets the wide range of size classification, and the ability to deposit the samples uniformly for inhalation research. The statement of work and specifications are attached.


This notice of intent is not a request for competitive quotations. Any party who believes they can perform this requirement should submit a capability statement for consideration by the government. A determination by the government not to compete this proposed contract based on responses to this notice is solely within the discretion of the government. Information received by the government as a result of this notice will be considered solely for the purpose of determining whether to conduct competitive procurement.


The government will not be responsible for any costs incurred by a party who responds to this notice. A party may identify their interest and submit a capability statement by 4pm (EST) on 17 June 2026.


Responses, including questions about this notice, should be sent via email to Contract Specialist, Aminah Gary at uuu0@cdc.gov

Similar Contracts

NAICS: 334516
New
Federal
FDA-RFQ- BioProfile FLEX2 Parts and Components-Brand Name or EqualThe contract solicitation seeks quotations for supplying parts and components compatible with three Nova BioProfile FLEX 2 instruments owned by the FDA’s Center for Drug Evaluation and Research (CDER). The requirement includes parts for two main FLEX2 instruments and an additional external sampling module, each identified by specific serial numbers. The contractor must provide new, unused, and defect-free commercial parts or equivalent consumables that fully function with the instruments in their current configuration, without requiring modifications. Delivered items must maintain at least 75% to 80% of their shelf life, and those requiring special conditions such as refrigeration or flammable item handling must comply with relevant regulations. Only manufacturers or authorized resellers may submit quotes, which are due via email by June 26, 2026. The contract period covers 12 consecutive months from the award date, with performance based at the FDA facility in Silver Spring, Maryland. The procurement process is issued as a combined synopsis/solicitation under commercial item acquisition rules, with no separate solicitation document forthcoming. The solicitation emphasizes strict adherence to delivery schedules and quality standards detailed in the attached Statement of Work. Communication and submission of quotations are managed through the designated FDA point of contact.
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 10 days
View Details
NAICS: 334516
New
Federal
NOI - Infors HT Multitron Incubation ShakerThe National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a combined synopsis/solicitation under the number 75N98026Q00639 for the procurement of an Infors HT Multitron Incubation Shaker, including integrated CO2 control, hygienic humidification, accessories, and installation. This purchase intends to extend a 15-year-old existing Multitron system used in the Laboratory of Structural Cell Biology at NHLBI. The solicitation is conducted as a non-competitive, sole-source action with Infors USA, the exclusive U.S. manufacturer and seller of this patented system, to ensure compatibility and integration with the existing equipment. The acquisition falls under the streamlined procedures outlined in FAR Subpart 12.6 and is not expected to exceed the simplified acquisition threshold. The solicitation is governed by Federal Acquisition Circular 2026-01, effective March 13, 2026, with the North American Industry Classification System (NAICS) code 334516 for Analytical Laboratory Instrument Manufacturing, and it is not set aside for small businesses. Proposals are requested promptly, with a response deadline of June 23, 2026. This action is authorized under FAR 12.603 and 41 U.S.C. 1901, reflecting the necessity of a direct award due to the unique integration requirements and the lack of comparable commercial items. The point of contact for this solicitation is Nicholas S. Capobianco at the NIH.
National Institutes Of Health Olao

POSTED

1 day ago

DEADLINE

in 6 days
View Details